Novartis announced it will move its UK headquarters from Frimley, Surrey to London, in a multi-million pound investment in UK life sciences.
The company will relocate to The WestWorks, White City Place, which is emerging as London’s latest life sciences cluster.
“The nature of healthcare and medicine is changing and as we pivot towards becoming a focused medicines company, powered by digital and data, we want to be closer to our customers and partners, and become better networked in the healthcare and life science ecosystem,” said Haseeb Ahmad, Novartis UK Country President.
“White City is quickly becoming one of the UK’s life sciences and technology districts, and the ethos of The WestWorks campus complements how we work to deliver on our strategy to reimagine medicine.”
White City Place is quickly becoming home to a number of pioneering life sciences companies, as well as Imperial College London’s major new research and innovation campus.
The new head office will be fully operational by the beginning of 2020.